Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherRevenue - RentalShares Issued
Ratios

Maxcyte (MXCT) Depreciation Expense (2024 - 2025)

Maxcyte (MXCT) has disclosed Depreciation Expense for 2 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Depreciation Expense changed 0.19% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Dec 2025, changed N/A year-over-year, with the annual reading at $4.3 million for FY2025, 0.65% down from the prior year.
  • Depreciation Expense for Q4 2025 was $1.1 million at Maxcyte, roughly flat from $1.1 million in the prior quarter.
  • The five-year high for Depreciation Expense was $1.1 million in Q2 2025, with the low at $1.1 million in Q4 2025.